Report ID
|
138198 |
Drug Identification Number
|
02012472 |
Brand name
|
LOVENOX |
Common or Proper name
|
Lovenox |
Company Name
|
SANOFI-AVENTIS CANADA INC |
Market Status
|
MARKETED |
Active Ingredient(s)
|
ENOXAPARIN SODIUM |
Strength(s)
|
30MG |
Dosage form(s)
|
SOLUTION |
Route of administration
|
SUBCUTANEOUS
SUBCUTANEOUS |
Packaging size
|
10 |
ATC code
|
B01AB |
ATC description
|
ANTITHROMBOTIC AGENTS |
Reason for shortage
|
Delay in shipping of the drug. |
Anticipated start date
|
2021-12-10 |
Actual start date
|
2021-12-10 |
Estimated end date
|
2022-01-14 |
Actual end date
|
2022-01-06 |
Shortage status
|
Resolved |
Updated date
|
2022-01-13 |
Company comments
|
The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments
|
|
Tier 3 Status
|
No |
Company contact information |
email: [email protected]
Telephone: 1-800-265-7927 |